Advances in PET/CT Imaging for Breast Cancer

Dorine de Jong, Elise Desperito, Karine A. Al Feghali, Laurent Dercle, Romain David Seban, Jeeban P. Das, Hong Ma, Abin Sajan, Brian Braumuller, Conor Prendergast, Connie Liou, Aileen Deng, Tina Roa, Randy Yeh, Antoine Girard, Mary M. Salvatore, Kathleen M. Capaccione

Research output: Contribution to journalReview articlepeer-review


One out of eight women will be affected by breast cancer during her lifetime. Imaging plays a key role in breast cancer detection and management, providing physicians with information about tumor location, heterogeneity, and dissemination. In this review, we describe the latest advances in PET/CT imaging of breast cancer, including novel applications of 18F-FDG PET/CT and the development and testing of new agents for primary and metastatic breast tumor imaging and therapy. Ultimately, these radiopharmaceuticals may guide personalized approaches to optimize treatment based on the patient’s specific tumor profile, and may become a new standard of care. In addition, they may enhance the assessment of treatment efficacy and lead to improved outcomes for patients with a breast cancer diagnosis.

Original languageEnglish
Article number4537
JournalJournal of Clinical Medicine
Issue number13
StatePublished - Jul 2023
Externally publishedYes


  • F-FDG
  • breast cancer
  • PET radiotracers
  • triple negative breast cancer (TNBC)


Dive into the research topics of 'Advances in PET/CT Imaging for Breast Cancer'. Together they form a unique fingerprint.

Cite this